Doris has made over 6 trades of the IRIDEX stock since 2011, according to the Form 4 filled with the SEC. Most recently she exercised 5,000 units of IRIX stock worth $81,900 on 25 May 2017.
The largest trade she's ever made was selling 33,750 units of IRIDEX stock on 12 September 2013 worth over $456,638. On average, Doris trades about 4,087 units every 96 days since 2004. As of 25 May 2017 she still owns at least 22,650 units of IRIDEX stock.
You can see the complete history of Ms. Engibous stock trades at the bottom of the page.
Doris E. Engibous serves as Independent Director of the Company. Ms. Engibous has been an independent consultant and advisor to medical technology companies and executives since 2010. She currently serves on the board of directors of Imricor Medical Systems Inc., a pioneer and leader in developing MRI-compatible products for cardiac catheter ablation procedures and GI Supply Inc., a family-owned provider of innovative medical products. Previously, Ms. Engibous served on the board of directors of Natus Medical Inc., a $500 million leading provider of healthcare products, as well as the National Kidney Foundation serving Minnesota, the Dakotas and Iowa. From 2004 to 2010, Ms. Engibous served as President and CEO of Hemosphere Inc., an early stage, venture capital funded medical technology company, prior to its acquisition by CryoLife Inc. Prior to 2004, Ms. Engibous served 18 years in several executive capacities at Nellcor and its successors Nellcor Puritan Bennett Inc., Mallinckrodt Inc., and Tyco Healthcare including President of Nellcor, and was responsible for the integration of Nellcor into Mallinckrodt and later Tyco Healthcare. She holds a Bachelor of Science degree in Chemical Engineering from the University of Michigan.
Doris Engibous is 65, she's been the Independent Director of IRIDEX since 2020. There are 3 older and 6 younger executives at IRIDEX. The oldest executive at IRIDEX Corp. is Robert Gunst, 72, who is the Independent Chairman of the Board.
Doris's mailing address filed with the SEC is 1212, Terra Bella Avenue, Mountain View, Santa Clara County, California, 94043, United States.
Over the last 21 years, insiders at IRIDEX have traded over $1,952,092 worth of IRIDEX stock and bought 1,330,571 units worth $7,196,100 . The most active insiders traders include Joshua Makower, James B Hawkins, and Capital Fund, Lp Acuta. On average, IRIDEX executives and independent directors trade stock every 32 days with the average trade being worth of $18,723. The most recent stock trade was executed by Nandini Devi on 20 May 2022, trading 2,000 units of IRIX stock currently worth $6,200.
iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.
IRIDEX executives and other stock owners filed with the SEC include: